Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice-Reference-Cited by-同舟云学术

Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice

Published:2014-08-17 Issue:4 Volume:10 Page:361-367
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Lok Sheau Wen¹²,Wong Hui-li²³,Kosmider Suzanne¹²,Field Kathryn²,Tie Jeanne¹²³,Desai Jayesh¹³,Bae Susie²,Tacey Mark⁴,Skinner Iain¹,Jones Ian²,Gibbs Peter¹²³

Affiliation:

1. Western Hospital; Royal Melbourne Hospital and University of Melbourne; Melbourne Victoria Australia

2. Royal Melbourne Hospital; Royal Melbourne Hospital and University of Melbourne; Melbourne Victoria Australia

3. Walter and Eliza Hall Institute; Royal Melbourne Hospital and University of Melbourne; Melbourne Victoria Australia

4. Melbourne EpiCentre; Royal Melbourne Hospital and University of Melbourne; Melbourne Victoria Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12260/fullpdf

Reference24 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;De Gramont;J Clin Oncol,2000

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

4. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer;Saltz;N Engl J Med,2000

5. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis;World Journal of Surgical Oncology;2020-09-29

2. MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5;Cancer Cell International;2020-04-10

3. “Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study;CANCER REPORTS;2019-05-30

4. Wnt/catenin β1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer;Oncology Letters;2018-01-26

5. How accurate are medical oncologists’ impressions of management of metastatic colorectal cancer in Australia?;Asia-Pacific Journal of Clinical Oncology;2017-03-16